StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)

Close on Nov 17, 2026Market cap $28.79MP/E –Yield –

Xtant Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Xtant Medical's operating income for the twelve months ending Jun 30, 2026 was -$10.50M, down 37582.1% year over year. For fiscal 2025 it was $7.28M. The highest annual figure on record is $7.28M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.28M–
FY2024Dec 31, 2024-$12.07M–
FY2023Dec 31, 2023-$10.16M–
FY2022Dec 31, 2022-$6.76M–
FY2021Dec 31, 2021-$3.85M–
FY2020Dec 31, 2020-$751.00K–
FY2019Dec 31, 2019-$2.25M–
FY2018Dec 31, 2018-$60.08M–
FY2017Dec 31, 2017-$37.83M–
FY2016Dec 31, 2016-$7.55M–
FY2015Dec 31, 2015-$12.08M–
FY2014Dec 31, 2014-$6.26M–
FY2013Dec 31, 2013-$9.01M–
FY2012Dec 31, 2012-$4.94M–
FY2011Dec 31, 2011-$6.45M–
FY2010Dec 31, 2010-$8.61M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.17M-298.3%
Q1 FY2026Mar 31, 2026-$2.92M-375.0%
Q4 FY2025Dec 31, 2025-$944.00K–
Q3 FY2025Sep 30, 2025$2.54M–
Q2 FY2025Jun 30, 2025$4.62M–
Q1 FY2025Mar 31, 2025$1.06M–
Q4 FY2024Dec 31, 2024-$1.88M–
Q3 FY2024Sep 30, 2024-$3.78M–
Q2 FY2024Jun 30, 2024-$2.95M–
Q1 FY2024Mar 31, 2024-$3.47M–
Q4 FY2023Dec 31, 2023-$3.81M–
Q3 FY2023Sep 30, 2023-$3.39M–
Q2 FY2023Jun 30, 2023-$1.39M–
Q1 FY2023Mar 31, 2023-$1.58M–
Q4 FY2022Dec 31, 2022-$1.72M–
Q3 FY2022Sep 30, 2022-$1.90M–
Q2 FY2022Jun 30, 2022-$1.30M–
Q1 FY2022Mar 31, 2022-$1.83M–
Q4 FY2021Dec 31, 2021-$1.91M-896.3%
Q3 FY2021Sep 30, 2021-$1.45M-290.1%
Q2 FY2021Jun 30, 2021-$491.00K–
Q1 FY2021Mar 31, 2021-$5.00K–
Q4 FY2020Dec 31, 2020$240.00K–
Q3 FY2020Sep 30, 2020$760.00K–
Q2 FY2020Jun 30, 2020-$387.00K–
Q1 FY2020Mar 31, 2020-$1.36M–
Q4 FY2019Dec 31, 2019-$318.00K–
Q3 FY2019Sep 30, 2019-$705.00K–
Q2 FY2019Jun 30, 2019-$563.00K–
Q1 FY2019Mar 31, 2019-$668.00K–
Q4 FY2018Dec 31, 2018-$54.73M–
Q3 FY2018Sep 30, 2018-$1.44M–
Q2 FY2018Jun 30, 2018-$2.26M–
Q1 FY2018Mar 31, 2018-$1.66M–
Q4 FY2017Dec 31, 2017-$24.24M–
Q3 FY2017Sep 30, 2017-$4.69M–
Q2 FY2017Jun 30, 2017-$6.35M–
Q1 FY2017Mar 31, 2017-$2.57M–
Q4 FY2016Dec 31, 2016-$1.16M–
Q3 FY2016Sep 30, 2016-$1.90M–

More Xtant Medical figures

See a number that looks wrong?